Jim Cramer Says CVS Health Corporation (CVS) Is Going To Be ‘Challenged In Every Part Of The Business’ - InvestingChannel

Jim Cramer Says CVS Health Corporation (CVS) Is Going To Be ‘Challenged In Every Part Of The Business’

We recently compiled a list of the Jim Cramer Talked About These 17 Stocks After The Fed’s Rate Cut. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks Jim Cramer recently talked about.

The Federal Reserve created quite a bit of turmoil in the stock market on Wednesday when despite cutting interest rates, it signaled to investors that the journey to low rates was far from over and would take longer than initially expected. Fed Chair Jerome Powell noted that “We have been moving sideways on 12-month inflation,” and used the data observation to project two rate cuts in 2025 instead of the earlier four.

In Squawk on the Street’s episode the day after the Fed’s rate cut, Cramer called the latest Fed outcome”a new phase in the process.” He outlined that the Fed might have missed the mark in being data-dependent. According to him “Look I think that they are data dependent. But they made a prediction and the prediction was not right. They should have just stayed data-dependent. They could’ve looked at the long bond and realized, you know wait a second, we’re on the wrong track here. And signal that. And they didn’t signal it.” Cramer was pressed about what Chair Powell got wrong, and in response, he shared that it was “The messaging. Right, because what happened is this that . . .we have a data-dependent Fed, and they chose not to be data-dependant.” Cramer added that the apparent miss from being data-dependant meant that the Fed’s “message was off. They’re not wrong, but all the people who thought that they were gonna be kind and dovish, I mean they were, uh, black dovish.”

The morning show host also shared his thoughts about the current tussle in Congress related to spending bills and electric vehicle billionaire Elon Musk’s role in it. “Look they got a real guy, Musk. Do you want to mess with Musk? I’m not messing with Musk. I tried it once. I was pantsed. You don’t want to be pantsed by this man,” said Cramer. He added “But I do want to make a point that there are a lot of people who are hopeful that he can do something about that. The $36 trillion that we have.” According to Cramer, to achieve the cut maybe Musk and his team “shame people, maybe he shames people who are giveaway guys,” as he believes that “he [MUSK] represents this chain of thought in this country that there’s hope. That this government can get its act together.”

Cramer’s remarks in the morning show weren’t the only ones covering the rate cut. Immediately after the cut, in Mad Money, he commented on Chair Powell “Because he seemed to get caught having to fulfill a prediction of the need for a rate cut, and that need was no longer self-evident. The data didn’t back it up. It would have been much better off if they had explicitly taken a wait-and-see approach before this meeting. This time they telegraphed the wrong thing. Hence today’s meltdown.”

Building on the comments, the next day he outlined “There were some very cogent questions at the press conference about whether, when you study it, after his statement, did they really need a cut? By their own admission? And, I think it confused people. It confused people because they cut rates and then gave exactly the, what I would call the [inaudible] for not cutting rates. David, this is that same problem that I keep saying which is that, if they had not set us up, not told certain people in the media, whatever, that we need a cut, and then they kind of like regretted it. And they regretted it because business is so strong, like GDP, inflation is a little bit higher.” Cramer concluded by stating that he believes the Fed “got trapped, Jay got trapped.”

As for China, the CNBC host didn’t mince any words either. According to him, China has  “done nothing but build up” its military. Cramer does not trust the Chinese either. Quoting from the former Trump Administration’s Secretary of Defense General Jim Mattis’ book, Cramer shared that where “the Chinese meet with Obama and they agree to everything and it’s really terrific and then they, a day later, they violate everything with the South China Sea.” Situations like these make him “think that we’ve been taken advantage of.”

Our Methodology

To make our list of the stocks that Jim Cramer talked about, we listed down all the stocks he mentioned during CNBC’s Squawk on the Street aired the day after the Fed’s rate cut.

For these stocks, we also mentioned the number of hedge fund investors. Why are we interested in the stocks that hedge funds invest in? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).

Top 15 Best-Selling Cancer Drugs A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products.

CVS Health Corporation (NYSE:CVS)

Number of Hedge Fund Holders In Q3 2024: 63

CVS Health Corporation (NYSE:CVS) is another embattled healthcare benefits manager. The firm has entered the current turmoil surrounding the industry with significant investor pessimism on its back. Soaring costs have led to a potential breakup of the firm, and CVS Health Corporation (NYSE:CVS) is also not only facing broader pessimism against the benefits management industry but it is also under fire from the Justice Department. The Department’s lawsuit claims that the benefits manager contributed to the opioid crisis, and similar suits in the past have cost upwards of $5 billion to resolve. All these factors were on Cramer’s mind when he discussed CVS Health Corporation (NYSE:CVS):

“I want to add to the danger. This is a Justice Department suit that was just filed. Not today, but, David, when you read this suit, I don’t think people have read it. This is about opiate. And we thought we settled all those cases. . . .Justice Department, Bobby Whelan, and last thing his Justice Department does, really going after them for opioids. [QUOTING FROM THE SUIT] “To reduce its labor costs, CVS set staffing levels so low that it was impossible for pharmacists to comply with their legal obligations.” Meaning that the pharmacists were not any sort of, they didn’t gate this. If anything they allowed opiates to be sold, but they bore unresolved red flags of invalidity and it didn’t matter. CVS pharmacists described working in CVS as “a soul-crushing experience. . .impossible to meet the company’s expectations.”

“What I’m saying is this that we all know you can’t get, it’s all lock and can’t see CVS in the front of the store. In the back, pharmacists just didn’t have the chance to be able to comply and stop opiates. And I’ve got to tell you David, this is one of those, they’ve got new management there but, this is not going to go away. They’re [JUSTICE DEPARTMENT] saying it really contributed to the opioid crisis.

“CVS is going to be challenged in every part of the business. And I don’t like this suit from the Justice Department. I don’t like it because, filed first of all in Rhode Island where CVS is. But there is a chance David, that they are going to be front and center again with opioids.”

“But there’s people buzzing if it’s the next Walgreens.

“By the way, I like these guys, they’re really trying to turn it, but David there’s a lot of damage. And this Justice Department suit is part of it.”

Overall CVS ranks 5th on our list of the stocks Jim Cramer recently talked about. While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CVS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire